HomeInsightsStock Comparison

Sakar Healthcare Ltd vs Zenlabs Ethica Ltd Stock Comparison

Sakar Healthcare Ltd vs Zenlabs Ethica Ltd Stock Comparison

Last Updated on: Jun 25, 2025

Key Highlights

  • The Latest Trading Price of Sakar Healthcare Ltd is ₹ 363.5 as of 24 Jun 15:30.
  • The P/E Ratio of Sakar Healthcare Ltd changed from 7.8 on March 2020 to 68.6 on March 2024 . This represents a CAGR of 54.47% over 5 yearsThe P/E Ratio of Zenlabs Ethica Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Sakar Healthcare Ltd changed from ₹ 74.73 crore on March 2020 to ₹ 801.05 crore on March 2024 . This represents a CAGR of 60.71% over 5 yearsThe Market Cap of Zenlabs Ethica Ltd changed from ₹ 0 crore on March 2020 to ₹ 0 crore on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The revenue of Sakar Healthcare Ltd for the Mar '25 is ₹ 50.42 crore as compare to the Dec '24 revenue of ₹ 43.71 crore. This represent the growth of 15.35% The revenue of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 revenue of ₹ 0 crore. This represent the decline of 0%.
  • The ebitda of Sakar Healthcare Ltd for the Mar '25 is ₹ 15.91 crore as compare to the Dec '24 ebitda of ₹ 12 crore. This represent the growth of 32.58% The ebitda of Zenlabs Ethica Ltd for the Mar '25 is ₹ 0 crore as compare to the Dec '24 ebitda of ₹ 0 crore. This represent the decline of 0%.
  • The net profit of Sakar Healthcare Ltd changed from ₹ 2.84 crore to ₹ 5.76 crore over 8 quarters. This represents a CAGR of 42.41% The net profit of Zenlabs Ethica Ltd changed from ₹ 0 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of 0.0% .
  • The Dividend Payout of Sakar Healthcare Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Zenlabs Ethica Ltd changed from 33.21 % on March 2023 to 0 % on March 2024 . This represents a CAGR of -100.00% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Sakar Healthcare Ltd

  • Sakar Healthcare Limited was incorporated as a Private Limited Company under the name 'Sakar Healthcare Private Limited on 26th March 2004.
  • Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to 'Sakar Healthcare Limited.
  • The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah. The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials & Lyophilized Injections and Oral Solid Dossages.
  • It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, anti-emetics, anti-histamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.

About Zenlabs Ethica Ltd

  • Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993.
  • The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
  • It deals into marketing and distribution of pharmaceutical products and has grown to be of India's top pharmaceutical companies in 2019. The Company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada.
  • The strength lies in quality, affordable and branded drugs in enhancing the quality of life of people.
  • Apart from this, it offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India.

Sakar Healthcare Ltd News Hub

News

Sakar Healthcare surges after receiving marketing authorization in EU for its oncology product

The company's dossier compiled under EU guidelines have fetched this second approval in co...

Read more

18 Jun 2025 14:13

News

Sakar Healthcare to discuss results

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 15 May 20...

Read more

10 May 2025 11:14

News

Sakar Healthcare to conduct board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 8 Februar...

Read more

03 Feb 2025 10:50

News

Sakar Healthcare schedules board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 22 Octobe...

Read more

18 Oct 2024 16:55

News

Sakar Healthcare to hold board meeting

Sakar Healthcare will hold a meeting of the Board of Directors of the Company on 13 August...

Read more

09 Aug 2024 16:37

News

Sakar Healthcare to convene AGM

Sakar Healthcare announced that the 20th Annual General Meeting (AGM) of the company will ...

Read more

23 Jul 2024 10:02

Zenlabs Ethica Ltd News Hub

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

08 May 2025 11:05

News

Zenlabs Ethica to declare Quarterly Results

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 May 2025...

Read more

07 May 2025 11:07

News

Zenlabs Ethica to hold board meeting

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 February ...

Read more

31 Jan 2025 15:48

News

Zenlabs Ethica to announce Quarterly Result

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 12 November...

Read more

07 Nov 2024 16:58

News

Zenlabs Ethica AGM scheduled

Zenlabs Ethica announced that the 31th Annual General Meeting (AGM) of the company will be...

Read more

30 Sep 2024 10:04

News

Zenlabs Ethica announces board meeting date

Zenlabs Ethica will hold a meeting of the Board of Directors of the Company on 7 August 20...

Read more

02 Aug 2024 10:30

SWOT Analysis Of Zenlabs Ethica Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Sakar Healthcare Ltd

Strength

2

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Zenlabs Ethica Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sakar Healthcare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Sakar Healthcare Ltd and Zenlabs Ethica Ltd

Which company has a larger market capitalization, Sakar Healthcare Ltd or Zenlabs Ethica Ltd?

Market cap of Sakar Healthcare Ltd is 797 Cr while Market cap of Zenlabs Ethica Ltd is 21 Cr

What are the key factors driving the stock performance of Sakar Healthcare Ltd and Zenlabs Ethica Ltd?

The stock performance of Sakar Healthcare Ltd and Zenlabs Ethica Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Sakar Healthcare Ltd and Zenlabs Ethica Ltd?

As of June 25, 2025, the Sakar Healthcare Ltd stock price is INR ₹363.5. On the other hand, Zenlabs Ethica Ltd stock price is INR ₹32.31.

How do dividend payouts of Sakar Healthcare Ltd and Zenlabs Ethica Ltd compare?

To compare the dividend payouts of Sakar Healthcare Ltd and Zenlabs Ethica Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions